Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eosinophilic cholangitis as an indeterminate biliary mimic: A systematic review of outcomes.

The American journal of the medical sciences·2026
Same author

Comparative Effectiveness of Bariatric Surgery Versus GLP-1 Receptor Agonists in Reducing the Risk of New-Onset of NASH: A Retrospective Multinational Cohort Study From North America and Europe.

Endocrinology, diabetes & metabolism·2025
Same author

Glucagon-like peptide-1 receptor agonists improve metabolic dysfunction-associated steatotic liver disease outcomes.

Scientific reports·2025
Same author

Pathophysiology of Hepatorenal Syndrome.

Advances in kidney disease and health·2024
Same author

Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study.

Hepatology communications·2023
Same author

Liver Disease During Pregnancy.

The American journal of gastroenterology·2022
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Related Experiment Video

Updated: Jun 29, 2025

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
10:30

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy

Published on: May 16, 2015

19.6K

Minimal Hepatic Encephalopathy.

Rachel Redfield1, Nyan Latt2, Santiago J Munoz3

  • 1Thomas Jefferson Hospital, Division of Gastroenterology, 132 S. 10th Street, Suite 480, Philadelphia, PA 19106, USA.

Clinics in Liver Disease
|March 28, 2024
PubMed
Summary
This summary is machine-generated.

Minimal hepatic encephalopathy (MHE) is a common complication of cirrhosis, often missed by standard exams. New diagnostic tools are improving the detection of MHE, a condition impacting daily life.

Keywords:
AmmoniaAttentionCirrhosisCognitiveConfusionCovertEncephalopathyMinimal

More Related Videos

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

11.8K
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.4K

Related Experiment Videos

Last Updated: Jun 29, 2025

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
10:30

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy

Published on: May 16, 2015

19.6K
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
07:27

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury

Published on: October 21, 2017

11.8K
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.4K

Area of Science:

  • Hepatology
  • Neurology
  • Clinical Diagnostics

Background:

  • Minimal hepatic encephalopathy (MHE) is a frequent complication in patients with cirrhosis.
  • Diagnosis of MHE is challenging due to normal neurological examinations and absence of overt hepatic encephalopathy (HE) symptoms.
  • MHE significantly impairs patients' quality of life and daily activities, including driving and operating machinery.

Purpose of the Study:

  • To highlight the diagnostic challenges of MHE in cirrhosis.
  • To discuss advancements in diagnostic tools for MHE detection.
  • To emphasize the impact of MHE on patients' daily lives.

Main Methods:

  • Review of current diagnostic approaches for MHE.
  • Discussion of emerging point-of-care diagnostic tools.
  • Analysis of the clinical impact of MHE on patient functioning.

Main Results:

  • Standard neurological examinations are insufficient for MHE diagnosis.
  • Progress has been made in developing tools to detect subtle cognitive and attention deficits.
  • MHE affects crucial daily activities, indicating a significant impact on patient well-being.

Conclusions:

  • Early and accurate diagnosis of MHE is crucial for managing cirrhosis patients.
  • Advancements in diagnostic technology are improving the identification of MHE.
  • Addressing MHE is essential to improve the quality of life for individuals with cirrhosis.